BIIB vs MAPSW · P/E 21, rev $9.89B vs rev $184.5M
Biogen Inc (BIIB) versus WM Technology Inc (MAPSW) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ.
WM Technology Inc (MAPSW) is a software - application company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported MAPSW revenue for 2024-12-31 was $184.5M. Net income was $12.2M. Revenue was down 1.9% from 2023-12-31 to 2024-12-31. MAPSW currently screens at market cap $2.68B.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. MAPSW currently screens at market cap $2.68B.
Not investment advice. Open the BIIB and MAPSW stock pages for the full models.
Not investment advice.